ConductScience.org, home

Paper12840783

New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

Pan TC and 5 others. Am J Hum Genet, 2003. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Papers, record 12840783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12840783

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
PubMed
Journal
Am J Hum Genet
PubMed
Year
2003
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
2.7
iCite
Revised in PubMed
2020-08-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan TCTe-Cheng
2Zhang RZRui-Zhu
3Sudano DGDominick G
4Marie SKSuely K
5Bönnemann CGCarsten G
6Chu MLMon-Li

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Collagen Type VIMajor topic
Muscular DystrophiesMajor topic
Amino Acid Sequence
Base Sequence
Child
DNA, Complementary
Dimerization
Exons
Extracellular Matrix
Fibroblasts
Genes, Dominant
Genotype
Heterozygote
Humans
Introns
Male
Molecular Sequence Data
Muscles
Phenotype
Protein Structure, Tertiary
RNA, Messenger
Sequence Deletion
Sequence Homology, Nucleic Acid

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AR038912NIAMS NIH HHSUnited StatesR01AR038912PubMed and NIH
AR38912NIAMS NIH HHSUnited StatesR01AR038912PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112374585Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy.Eur J Paediatr Neurol2002https://conductscience.org/library/papers/12374585PubMed
212297580Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness.Neurology2002https://conductscience.org/library/papers/12297580PubMed
312424008Defective glycosylation in muscular dystrophy.Lancet2002https://conductscience.org/library/papers/12424008PubMed
412218063Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy.J Biol Chem2002https://conductscience.org/library/papers/12218063PubMed
5963533Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees.Brain1976https://conductscience.org/library/papers/963533PubMed
63198591Amino acid sequence of the triple-helical domain of human collagen type VI.J Biol Chem1988https://conductscience.org/library/papers/3198591PubMed
72651568Ullrich's congenital atonic sclerotic muscular dystrophy. A case report.J Neurol1989https://conductscience.org/library/papers/2651568PubMed
82551668
Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus.
EMBO J1989https://conductscience.org/library/papers/2551668PubMed
91689238Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors.EMBO J1990https://conductscience.org/library/papers/1689238PubMed
102203776Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth.J Biol Chem1990https://conductscience.org/library/papers/2203776PubMed
111867713The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper.Annu Rev Biophys Biophys Chem1991https://conductscience.org/library/papers/1867713PubMed
121425570Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan.EMBO J1992https://conductscience.org/library/papers/1425570PubMed
138168508Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI.Eur J Biochem1994https://conductscience.org/library/papers/8168508PubMed
147773292The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription.Nat Genet1995https://conductscience.org/library/papers/7773292PubMed
157596809Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript.Nucleic Acids Res1995https://conductscience.org/library/papers/7596809PubMed
168575781Head to tail organization of the human COL6A1 and COL6A2 genes by fiber-FISH.Genomics1995https://conductscience.org/library/papers/8575781PubMed
178782832Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.Nat Genet1996https://conductscience.org/library/papers/8782832PubMed
189334230Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen.J Biol Chem1997https://conductscience.org/library/papers/9334230PubMed
199468540Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation.J Biol Chem1998https://conductscience.org/library/papers/9468540PubMed
209516440
The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line.
J Biol Chem1998https://conductscience.org/library/papers/9516440PubMed

See all 40 referencesDownload CSV of references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
41439068Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy.Cureus2025https://conductscience.org/library/papers/41439068PubMed
40225172The UCMD-Causing COL6A1 (c.930 + 189C > T) Intron Mutation Leads to the Secretion and Aggregation of Single Mutated Collagen VI α1 Chains.Hum Mutat2023https://conductscience.org/library/papers/40225172PubMed
40177858Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.Brain2025https://conductscience.org/library/papers/40177858PubMed
39595588Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts.Biomolecules2024https://conductscience.org/library/papers/39595588PubMed
38937821The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.J Biomed Sci2024https://conductscience.org/library/papers/38937821PubMed
38617974Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38617974PubMed
38585825
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
medRxiv2024https://conductscience.org/library/papers/38585825PubMed
37686358Features of Congenital Arthrogryposis Due to Abnormalities in Collagen Homeostasis, a Scoping Review.Int J Mol Sci2023https://conductscience.org/library/papers/37686358PubMed
37569848New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients.Int J Mol Sci2023https://conductscience.org/library/papers/37569848PubMed
36982167Collagen VI in the Musculoskeletal System.Int J Mol Sci2023https://conductscience.org/library/papers/36982167PubMed
35832501Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report.Acta Myol2022https://conductscience.org/library/papers/35832501PubMed
34729958Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsies.Ann Clin Transl Neurol2021https://conductscience.org/library/papers/34729958PubMed
34167565Causative variant profile of collagen VI-related dystrophy in Japan.Orphanet J Rare Dis2021https://conductscience.org/library/papers/34167565PubMed
33250842Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.Front Neurol2020https://conductscience.org/library/papers/33250842PubMed
32585628Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/32585628PubMed
31387942Basement membrane collagens and disease mechanisms.Essays Biochem2019https://conductscience.org/library/papers/31387942PubMed
30895940A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies.JCI Insight2019https://conductscience.org/library/papers/30895940PubMed
30174616Extracellular Collagen VI Has Prosurvival and Autophagy Instructive Properties in Mouse Fibroblasts.Front Physiol2018https://conductscience.org/library/papers/30174616PubMed
29067961Genetic and Clinical Advances of Congenital Muscular Dystrophy.Chin Med J (Engl)2017https://conductscience.org/library/papers/29067961PubMed
28831785Clinical, Pathologic, and Genetic Features of Collagen VI-Related Myopathy in Korea.J Clin Neurol2017https://conductscience.org/library/papers/28831785PubMed

See all 57 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
COL6A11291PubTator's text mininghttps://conductscience.org/library/genes/1291NCBI Gene
COL6A21292PubTator's text mininghttps://conductscience.org/library/genes/1292NCBI Gene
COL6A31293PubTator's text mininghttps://conductscience.org/library/genes/1293NCBI Gene

Download CSV of genes

Data4

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKX52022GENBANK
RefSeqNM_001849RefSeq
RefSeqNM_011515RefSeq
RefSeqNT_005210RefSeq

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12840783

GET https://conductscience.org/api/papers/v1/12840783/references?page=2